HMGCR genetic variation and risk of new-onset type 2 diabetes in statin users
Abstract Background Statins are widely prescribed lipid-lowering agents, but their use is associated with an increased risk of new-onset type 2 diabetes mellitus (NO-T2DM) ranging from 9% to 13%. While genetic variants in 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the pharmacological target o...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMC
2026-04-01
|
| Reeks: | Human Genomics |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1186/s40246-026-00962-7 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|